Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3637951000168115 | Crysanal (naproxen sodium 550 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3637961000168118 | Crysanal 550 mg tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Crysanal 550 mg tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Crysanal 550 mg tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Crysanal 550 mg tablet | Is a | Crysanal | true | Inferred relationship | Some | ||
| Crysanal 550 mg tablet | Is a | naproxen sodium 550 mg tablet | true | Inferred relationship | Some | ||
| Crysanal 550 mg tablet | has manufactured dose form | film-coated tablet | false | Inferred relationship | Some | ||
| Crysanal 550 mg tablet | has Australian BoSS | naproxen sodium | true | Inferred relationship | Some | 965074767 | |
| Crysanal 550 mg tablet | has intended active ingredient | naproxen | true | Inferred relationship | Some | 965074767 | |
| Crysanal 550 mg tablet | has unit of use | tablet | true | Inferred relationship | Some | 965074768 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Crysanal 550 mg tablet, 50 | has TPUU | True | Crysanal 550 mg tablet | Inferred relationship | Some | 1 |
| Crysanal 550 mg tablet, 50, blister pack | has TPUU | True | Crysanal 550 mg tablet | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR